DD119586A5 - - Google Patents

Info

Publication number
DD119586A5
DD119586A5 DD183151A DD18315174A DD119586A5 DD 119586 A5 DD119586 A5 DD 119586A5 DD 183151 A DD183151 A DD 183151A DD 18315174 A DD18315174 A DD 18315174A DD 119586 A5 DD119586 A5 DD 119586A5
Authority
DD
German Democratic Republic
Application number
DD183151A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2365102A external-priority patent/DE2365102C2/de
Priority claimed from DE19742441284 external-priority patent/DE2441284C2/de
Priority claimed from DE19742444618 external-priority patent/DE2444618C2/de
Application filed filed Critical
Publication of DD119586A5 publication Critical patent/DD119586A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0095Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 carbon in position 21 is part of carboxylic group

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD183151A 1973-12-21 1974-12-18 DD119586A5 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2365102A DE2365102C2 (de) 1973-12-21 1973-12-21 Neue Pregnansäure-Derivate
DE19742441284 DE2441284C2 (de) 1973-12-21 1974-08-27 Verfahren zur Herstellung von Pregnansäure-Derivaten
DE19742444618 DE2444618C2 (de) 1974-09-16 1974-09-16 Neue Pregnan-21-säure-Derivate

Publications (1)

Publication Number Publication Date
DD119586A5 true DD119586A5 (xx) 1976-05-05

Family

ID=27185702

Family Applications (1)

Application Number Title Priority Date Filing Date
DD183151A DD119586A5 (xx) 1973-12-21 1974-12-18

Country Status (22)

Country Link
US (1) US3944577A (xx)
JP (1) JPS5840559B2 (xx)
AT (2) AT347612B (xx)
AU (1) AU496759B2 (xx)
BE (1) BE823682A (xx)
CA (1) CA1060885A (xx)
CH (1) CH612688A5 (xx)
DD (1) DD119586A5 (xx)
DK (1) DK139361C (xx)
EG (1) EG11731A (xx)
ES (1) ES433216A1 (xx)
FI (1) FI53708C (xx)
FR (1) FR2255079B1 (xx)
GB (1) GB1497265A (xx)
IE (1) IE40456B1 (xx)
IL (1) IL46296A (xx)
IT (1) IT1043908B (xx)
NL (1) NL7416805A (xx)
NO (1) NO744623L (xx)
PH (1) PH11030A (xx)
SE (1) SE410607B (xx)
YU (1) YU338574A (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039668A (en) * 1973-06-23 1977-08-02 Schering Aktiengesellschaft Corticoid-containing inhalants
DK118776A (da) * 1975-03-21 1976-09-22 Schering Ag Pregnansyrederivater
US4181720A (en) * 1978-04-05 1980-01-01 Syntex (U.S.A.) Inc. Corticosteroid antiinflammatory agents
US4257969A (en) * 1980-01-23 1981-03-24 E. R. Squibb & Sons, Inc. 16,17-Dihydroxypregnene-21-carboxylic acids and derivatives
US4588530A (en) * 1982-07-30 1986-05-13 Florida Agricultural And Mechanical University Anti-inflammatory prednisolone steroids
US4511511A (en) * 1982-12-15 1985-04-16 Crozer-Chester Medical Center Prednisolone derivatives
US4897260A (en) * 1987-05-22 1990-01-30 The Rockefeller University Compositions that affect suppression of cutaneous delayed hypersensitivity and products including same
JP3176075B2 (ja) * 1991-03-04 2001-06-11 帝國製薬株式会社 新規なステロイド誘導体
PL370764A1 (en) * 2001-10-05 2005-05-30 Combinatorx, Incorporated Combinations for the treatment of immunoinflammatory disorders
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
WO2007139753A2 (en) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
WO2009038708A1 (en) * 2007-09-19 2009-03-26 Combinatorx, Incorporated Therapeutic regimens for the treatment of immunoinflammatory disorders
US20110189293A1 (en) * 2007-12-17 2011-08-04 CombinatoRx, Incoporated Therapeutic regimens for the treatment of immunoinflammatory disorders
JP7330718B2 (ja) 2019-02-28 2023-08-22 三菱重工業株式会社 ガスタービンプラント、及びその排出二酸化炭素回収方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833563A (en) * 1971-10-04 1974-09-03 Schering Ag Novel pregnanoic acid derivatives
US3828080A (en) * 1972-01-20 1974-08-06 Glaxo Lab Ltd Androstane-17beta-carboxylic acids and processes for the preparation thereof
DE2260303C2 (de) * 1972-12-06 1983-12-15 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von Pregnansäurederivaten

Also Published As

Publication number Publication date
JPS5840559B2 (ja) 1983-09-06
YU338574A (en) 1982-05-31
DK139361B (da) 1979-02-05
AT355744B (de) 1980-03-25
GB1497265A (en) 1978-01-05
FR2255079A1 (xx) 1975-07-18
NO744623L (xx) 1975-07-21
IL46296A (en) 1978-10-31
PH11030A (en) 1977-10-25
IT1043908B (it) 1980-02-29
DK667574A (xx) 1975-09-08
SE410607B (sv) 1979-10-22
IE40456L (en) 1975-06-21
SE7416038L (xx) 1975-06-23
NL7416805A (nl) 1975-06-24
DK139361C (da) 1979-07-09
EG11731A (en) 1977-11-30
ATA398978A (de) 1979-08-15
IL46296A0 (en) 1975-03-13
FI53708C (fi) 1978-07-10
AU7658574A (en) 1976-06-24
BE823682A (fr) 1975-06-20
CA1060885A (en) 1979-08-21
ATA1021774A (de) 1978-05-15
AU496759B2 (en) 1978-10-26
CH612688A5 (xx) 1979-08-15
JPS5095257A (xx) 1975-07-29
FI53708B (xx) 1978-03-31
IE40456B1 (en) 1979-06-06
ES433216A1 (es) 1977-03-01
US3944577A (en) 1976-03-16
FR2255079B1 (xx) 1978-02-03
FI370774A (xx) 1975-06-22
AT347612B (de) 1979-01-10

Similar Documents

Publication Publication Date Title
AR201758A1 (xx)
AU476761B2 (xx)
AU465372B2 (xx)
AR201235Q (xx)
AR201231Q (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU474838B2 (xx)
AU471343B2 (xx)
AU465453B2 (xx)
AU465434B2 (xx)
DK667574A (xx)
AU450229B2 (xx)
AU476714B2 (xx)
AR201229Q (xx)
AU466283B2 (xx)
AU476696B2 (xx)
AU472848B2 (xx)
AR199451A1 (xx)
AU477823B2 (xx)
AR197627A1 (xx)
AU447540B2 (xx)
AR200256A1 (xx)
AR201432A1 (xx)
AU477824B2 (xx)